Clinical and molecular signature of survival and resistance to olaparib plus pegylated liposomal doxorubicin in platinum-resistant ovarian cancer: A stratified analysis from the phase II clinical trial ROLANDO, GEICO-1601

1. Perez-Fidalgo, J.A.
2. Guerra, E.
3. García, Y.
4. Iglesias, M.
5. Hernández-Sosa, M.
6. Estevez-García, P.
7. Manso Sánchez, L.
8. Santaballa, A.
9. Oaknin, A.
10. Redondo, A.
11. Rubio, M.J.
12. González-Martín, A.